Management of Brain Hemorrhage
For acute intracerebral hemorrhage (ICH), immediately lower systolic blood pressure to a target of 130-150 mm Hg within 1 hour of presentation (if SBP is 150-220 mm Hg), reverse any coagulopathy, and arrange urgent neurosurgical consultation for patients with cerebellar hemorrhage ≥15 mL or those with neurological deterioration. 1
Blood Pressure Management
The cornerstone of acute ICH management is rapid, controlled blood pressure reduction:
- Initiate treatment within 2 hours of ICH onset and reach target SBP within 1 hour 1
- Target SBP: 130-150 mm Hg for patients with mild-to-moderate ICH presenting with SBP 150-220 mm Hg 1
- Avoid SBP <130 mm Hg - this is potentially harmful and associated with worse outcomes 1
- Minimize blood pressure variability - smooth, sustained control is critical. High SBP variability during the first 24 hours is independently associated with death and severe disability 1
Recent pooled analysis demonstrates that achieving "SBP reduction with stability" (reaching and maintaining SBP 130-150 mm Hg within the first hour) significantly improves functional independence (OR 1.38) and reduces neurological deterioration (OR 0.68) 2. However, only 30% of patients achieve this target, highlighting the need for aggressive early management.
Choice of antihypertensive agent: Use any IV agent with rapid onset and short duration for easy titration. Nicardipine is commonly used. Avoid venous vasodilators as they may worsen intracranial pressure 1.
Coagulopathy Reversal
Immediate reversal of anticoagulation is essential to prevent hematoma expansion, which occurs most frequently in the first hours and strongly predicts mortality 3, 4.
Surgical Management
Supratentorial ICH
- Craniotomy for hematoma evacuation may be considered as a life-saving measure in patients who are neurologically deteriorating, despite unclear overall functional benefit 1
- The STICH trials showed no benefit in functional outcome with routine craniotomy, but a 21% crossover rate from medical to surgical management (74% due to deterioration) suggests surgery may prevent death in deteriorating patients 1
- Minimally invasive techniques may offer value and deserve further evaluation 5
Cerebellar ICH
Immediate surgical removal with or without external ventricular drain (EVD) is strongly recommended for patients with: 1
- Neurological deterioration
- Brainstem compression and/or hydrocephalus from ventricular obstruction
- Cerebellar ICH volume ≥15 mL
This is a Class 1 recommendation to reduce mortality. EVD alone may be harmful if basal cisterns are compressed, as it may be insufficient when intracranial hypertension impedes brainstem blood supply 1.
Critical Care Priorities
Beyond blood pressure and surgical considerations, acute management focuses on:
- Preventing hematoma expansion - the primary driver of early mortality 3, 4
- Managing elevated intracranial pressure 3
- Seizure management 3
- Metabolic and temperature control 3
- Admission to neurocritical care unit when available 6
Common Pitfalls
- Overly aggressive BP lowering - dropping SBP below 130 mm Hg is harmful 1
- Delayed treatment initiation - the therapeutic window is narrow; treatment must begin within 2 hours 1
- Large BP fluctuations - variability is as harmful as absolute values; smooth titration is essential 1
- EVD alone for cerebellar ICH with brainstem compression - this may be insufficient or harmful 1
- Premature prognostication - avoid nihilistic care decisions in the acute phase 3
Time-Sensitive Care Pathway
Emerging evidence supports bundled, time-sensitive care pathways to reduce delays and optimize outcomes 3. The management sequence should be:
- Rapid neuroimaging (immediate)
- BP reduction initiation (within 2 hours, target reached within 1 hour)
- Coagulopathy reversal (immediate if applicable)
- Neurosurgical consultation (urgent for cerebellar ICH or deterioration)
- ICU admission with neurocritical care expertise
The severity of large or severe ICH requiring surgical decompression makes intensive BP lowering less well-established in terms of safety and efficacy - these patients require individualized assessment 1.